Among the best-known examples are the amplifications of MYCN and MYC oncogenes in neuroblastoma and acute myeloid leukaemia (AML), respectively, in double minutes or HSR structures [41,42]. The gene discussed is MYC; the disease is acute myeloid leukemia.